Our findings indicate that the C1 subtype and low-risk group exhibit stronger immune cell infiltration, particularly the active infiltration of CD8+ T cells and dendritic cells, which play key roles in tumor immune responses. The gene discussed is CD8A; the disease is neoplasm.